Effect of substance P on basal and thyrotropin-releasing hormone-stimulated thyrotropin release in humans.
To test the possible effects of intravenous administration of substance P (SP) on basal and thyrotropin-releasing hormone (TRH)-stimulated thyrotropin (TSH) release, SP was infused alone (0.5 or 1.5 pmol/kg-1/min-1 for 60 minutes) or after TRH (20 or 400 micrograms in an intravenous bolus) in 21 normal male subjects (aged 26 to 36 years) and in 18 normal women (aged 25 to 32 years). Women were studied during follicular (day 6 to 8) and luteal (day 21 to 23) phases of following regular menstrual cycles. In addition, plasma cortisol levels during SP infusion were measured. In agreement with previous findings, significant increments in plasma cortisol levels were observed in men and women when the higher (1.5 pmol/kg-1/min-1) but not the lower (0.5 pmol/kg-1/min-1) amount of SP was administered. In contrast, in both men and women basal and TRH (20 or 400 mg)-induced TSH releases were not modified by SP at any tested amount. Results in the follicular and luteal phase were similar. These data suggest that in normal men and women plasma SP is not involved in the control of TSH release, at least not outside the blood-brain barrier.
Coiro
V
V
Department of Internal Medicine, School of Medicine, University of Parma, Italy.
Volpi
R
R
Capretti
L
L
Gramellini
D
D
Cigarini
C
C
Papadia
C
C
Caiazza
A
A
Caffarri
G
G
Caffarra
P
P
Chiodera
P
P
D000328:Adult; D004305:Dose-Response Relationship, Drug; D005260:Female; D005498:Follicular Phase / Q000097:blood; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007262:Infusions, Intravenous; D008183:Luteal Phase / Q000097:blood; D008297:Male; D013373:Substance P / Q000494:pharmacology*; D013972:Thyrotropin / Q000097:blood*; D013973:Thyrotropin-Releasing Hormone / Q000494:pharmacology*
D013373:Substance P; D013973:Thyrotropin-Releasing Hormone; D013972:Thyrotropin; D006854:Hydrocortisone